Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Topical minoxidil effectively treats male pattern baldness and prevents hair loss.

PRP therapy increases hair density for androgenetic alopecia.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Exposure to Corexit dispersants during the oil spill cleanup was linked to increased respiratory and eye irritation symptoms in workers.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Dupilumab helps children with alopecia areata regrow hair safely.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Combining platelet-rich plasma with 5% minoxidil solution improves hair regrowth in androgenetic alopecia patients.

Finasteride works better for hair loss in patients 26 or younger.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Topical minoxidil improves female pattern hair loss, finasteride not effective, laser devices show mixed results.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Hair regrowth doesn't convert thin hairs to thick hairs, but increases overall hair density.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Minoxidil effectively lowers blood pressure in resistant cases, but needs beta-blocker and diuretic support.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

Adolescents with severe alopecia incur significantly higher healthcare costs.